Cargando…
Alteration of the exDNA profile in blood serum of LLC-bearing mice under the decrease of tumour invasion potential by bovine pancreatic DNase I treatment
Taking into account recently obtained data indicating the participation of circulating extracellular DNA (exDNA) in tumorigenesis, enzymes with deoxyribonucleic activity have again been considered as potential antitumour and antimetastatic drugs. Previously, using murine Lewis lung carcinoma and hep...
Autores principales: | Alekseeva, Ludmila A., Mironova, Nadezhda L., Brenner, Evgenyi V., Kurilshikov, Alexander M., Patutina, Olga A., Zenkova, Marina A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319761/ https://www.ncbi.nlm.nih.gov/pubmed/28222152 http://dx.doi.org/10.1371/journal.pone.0171988 |
Ejemplares similares
-
MicroRNA Drop in the Bloodstream and MicroRNA Boost in the Tumour Caused by Treatment with Ribonuclease A Leads to an Attenuation of Tumour Malignancy
por: Mironova, Nadezhda, et al.
Publicado: (2013) -
The systemic tumor response to RNase A treatment affects the expression of genes involved in maintaining cell malignancy
por: Mironova, Nadezhda, et al.
Publicado: (2017) -
Human Recombinant DNase I (Pulmozyme(®)) Inhibits Lung Metastases in Murine Metastatic B16 Melanoma Model That Correlates with Restoration of the DNase Activity and the Decrease SINE/LINE and c-Myc Fragments in Blood Cell-Free DNA
por: Alekseeva, Ludmila, et al.
Publicado: (2021) -
Targeting Circulating SINEs and LINEs with DNase I Provides Metastases Inhibition in Experimental Tumor Models
por: Alekseeva, Ludmila A., et al.
Publicado: (2020) -
Tumoricidal Activity of RNase A and DNase I
por: Patutina, O.A., et al.
Publicado: (2010)